Lu 38-012

Lu 38-012
Clinical data
Other namesLU-38012; LU38012
Drug classDopamine D4 receptor antagonist
ATC code
  • None
Identifiers
  • 5-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-1H-indole
PubChem CID
ChemSpider
Chemical and physical data
FormulaC19H20ClN3
Molar mass325.84 g·mol−1
3D model (JSmol)
  • C1CN(CCN1CC2=CC3=C(C=C2)NC=C3)C4=CC=C(C=C4)Cl
  • InChI=1S/C19H20ClN3/c20-17-2-4-18(5-3-17)23-11-9-22(10-12-23)14-15-1-6-19-16(13-15)7-8-21-19/h1-8,13,21H,9-12,14H2
  • Key:LFXXDQVEFFXFSD-UHFFFAOYSA-N

Lu 38-012 is a potent and selective dopamine D4 receptor antagonist which has been used in scientific research. It has an affinity (Ki) for the dopamine D4.2 receptor of 7.5 nM and showed 16-fold selectivity for this receptor over the dopamine D2S receptor (Ki = 120 nM). The drug had relatively little affinity for other dopamine receptors. Affinities at other targets have also been reported. The drug produces hypolocomotion and reverses dextroamphetamine- and phencyclidine (PCP)-induced hyperlocomotion without producing catalepsy in rodents. Lu 38-012 partially substituted for clozapine in drug discrimination tests in rodents. It was developed by Lundbeck and was first described in the scientific literature by 2006.

See also